Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04156490 · ClinicalTrials.gov registry record
Osmotic Agent Use in Middle Cerebral Artery Stroke
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 100
- Enrollment target
NCT04156490 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 100 participants.
The verdict
NCT04156490 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is a retrospective chart review of patients that were admitted with large MCA stroke to the Fairview system hospitals between December 2017-December 2018. Patients ischemic stroke volumes will be measured by taking the area of the infarction and multiplying it by the thickness of each CT or MRI slice, the summation of these volumes is the final volume of the ischemic lesion in cubic centimeters. Patients with stroke volumes greater than 70 cc will be included in the study. Patient midline shift will be measured in millimeters at the level of foramen of Monroe anytime during their initial admission and all patients with a shift greater than 1mm will be included. The midline shift will be documented on the first follow-up brain scan (CT or MRI) at least six hours after the initiation of osmotic therapy. Data will be collected from patient charts including: Age, sex, NIHSS on presentation and discharge, history of diabetes mellitus, hypertension, coronary artery disease, atrial fibrillation, and chronic kidney disease. The type of osmotherapy, along with change in serum sodium or osmolality and dose, will also be documented. In patients that did not receive osmotherapy, midline shift will be documented on the first 24-hour scan and every subsequent scan in 24-hour intervals. Death during a hospital stay will also be recorded. The investigators will use the SAS statistical suite to analyze this data.
Interventions
- OTHER No intervention is planned, this will be a purely retrospective trial.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-02-10 |
| Est. Completion | 2019-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04156490
The ClinicalTrials.gov registry entry for NCT04156490 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is planned, this will be a purely retrospective trial. is the first listed.
NCT04156490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04156490 about?
NCT04156490 is a clinical study titled "Osmotic Agent Use in Middle Cerebral Artery Stroke". This is a retrospective chart review of patients that were admitted with large MCA stroke to the Fairview system hospitals between December 2017-December 2018. Patients ischemic stroke volumes will be measured by taking the area of the infarction and multiplying it by the thickness of each CT or MRI...
What is the current status of trial NCT04156490?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2018-02-10. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT04156490?
The interventions under investigation include: No intervention is planned, this will be a purely retrospective trial. (OTHER).
Who is sponsoring clinical trial NCT04156490?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.